99mTc-labelled and pH-awakened microbeads entrapping surface-modified lipid nanoparticles for the augmented effect of oxaliplatin in the therapy of colorectal cancer.

Published in: Journal of microencapsulation (2020)

In conclusion, developed MBs formulation (99mTc-EuB-FA-SLN-OP) suggested promising results against therapy of CRC using dual targeting (i.e. ligand-directed and pH-awakened) approach.

Keyphrases

drug delivery
squamous cell carcinoma
stem cells
early stage
fatty acid
bone marrow
sentinel lymph node
cell therapy
chemotherapy induced